<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wen Z</submitter><funding>BLRD VA</funding><funding>NIA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>313-325</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6396296</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(3)</volume><pubmed_abstract>N-myristoyltransferase (NMT) attaches the fatty acid myristate to the N-terminal glycine of proteins to sort them into soluble and membrane-bound fractions. Function of the energy-sensing AMP-activated protein kinase, AMPK, is myristoylation dependent. In rheumatoid arthritis (RA), pathogenic T cells shift glucose away from adenosine tri-phosphate production toward synthetic and proliferative programs, promoting proliferation, cytokine production, and tissue invasion. We found that RA T cells had a defect in NMT1 function, which prevented AMPK activation and enabled unopposed mTORC1 signaling. Lack of the myristate lipid tail disrupted the lysosomal translocation and activation of AMPK. Instead, myristoylation-incompetent RA T cells hyperactivated the mTORC1 pathway and differentiated into pro-inflammatory TH1 and TH17 helper T cells. In vivo, NMT1 loss caused robust synovial tissue inflammation, whereas forced NMT1 overexpression rescued AMPK activation and suppressed synovitis. Thus, NMT1 has tissue-protective functions by facilitating lysosomal recruitment of AMPK and dampening mTORC1 signaling.</pubmed_abstract><journal>Nature immunology</journal><pubmed_title>N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation.</pubmed_title><pmcid>PMC6396296</pmcid><funding_grant_id>R01 HL142068</funding_grant_id><funding_grant_id>R01 AG045779</funding_grant_id><funding_grant_id>U19 AI057266</funding_grant_id><funding_grant_id>R01 AR042527</funding_grant_id><funding_grant_id>R01 HL117913</funding_grant_id><funding_grant_id>I01 BX001669</funding_grant_id><funding_grant_id>R01 AI108891</funding_grant_id><funding_grant_id>P01 HL129941</funding_grant_id><funding_grant_id>R01 AI108906</funding_grant_id><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Tian L</pubmed_authors><pubmed_authors>Weyand CM</pubmed_authors><pubmed_authors>Wen Z</pubmed_authors><pubmed_authors>Wu B</pubmed_authors><pubmed_authors>Shen Y</pubmed_authors><pubmed_authors>Shoor S</pubmed_authors><pubmed_authors>Jin K</pubmed_authors><pubmed_authors>Roche NE</pubmed_authors><pubmed_authors>Goronzy JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation.</name><description>N-myristoyltransferase (NMT) attaches the fatty acid myristate to the N-terminal glycine of proteins to sort them into soluble and membrane-bound fractions. Function of the energy-sensing AMP-activated protein kinase, AMPK, is myristoylation dependent. In rheumatoid arthritis (RA), pathogenic T cells shift glucose away from adenosine tri-phosphate production toward synthetic and proliferative programs, promoting proliferation, cytokine production, and tissue invasion. We found that RA T cells had a defect in NMT1 function, which prevented AMPK activation and enabled unopposed mTORC1 signaling. Lack of the myristate lipid tail disrupted the lysosomal translocation and activation of AMPK. Instead, myristoylation-incompetent RA T cells hyperactivated the mTORC1 pathway and differentiated into pro-inflammatory TH1 and TH17 helper T cells. In vivo, NMT1 loss caused robust synovial tissue inflammation, whereas forced NMT1 overexpression rescued AMPK activation and suppressed synovitis. Thus, NMT1 has tissue-protective functions by facilitating lysosomal recruitment of AMPK and dampening mTORC1 signaling.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2024-11-20T15:32:19.015Z</modification><creation>2019-08-07T07:03:22Z</creation></dates><accession>S-EPMC6396296</accession><cross_references><pubmed>30718913</pubmed><doi>10.1038/s41590-018-0296-7</doi></cross_references></HashMap>